Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
19
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Shipton Michael | Chief Commercial Officer | 11 | $0 | $0 | 2024-03-12 |
| Thermo Fisher Scientific Powder Holdings II | 10% Owner | 1 | $0 | $0 | 2024-03-12 |
| Tiwari Neil | Other | 8 | $0 | $0 | 2024-03-12 |
| Forman Darcy | Chief Delivery Officer | 23 | $0 | $0 | 2024-03-12 |
| Coman David | Chief Executive Officer | 17 | $0 | $0 | 2024-03-12 |
| Cotliar Jonathan | Chief Medical Officer | 33 | $0 | $0 | 2024-03-12 |
| Zaranek Mike | Chief Financial Officer | 19 | $0 | $0 | 2024-03-12 |
| Rollins Emily | Other | 8 | $0 | $0 | 2024-03-12 |
| Faulkner Robert C. | Other | 5 | $0 | $0 | 2024-03-12 |
| Green Jeremy | Other | 9 | $0 | $0 | 2024-03-12 |
| Hubbard John W | Other | 12 | $0 | $0 | 2024-03-12 |
| Jaguar Holding Co I, LLC | 10% Owner | 1 | $0 | $0 | 2024-03-12 |
| von Autenried Paul | Other | 6 | $0 | $0 | 2024-03-12 |
| Pellizzari Christine A | Chief Legal and HR Officer | 21 | $4.1K | $0 | 2024-03-12 |
| Bryenton Troy | Chief Technology Officer | 1 | $0 | $0 | 2023-05-11 |
| Geffon Steven | Chief Commercial Officer | 5 | $0 | $0 | 2022-08-12 |
| Goulburn Adam | Director | 3 | $0 | $0 | 2022-05-23 |
| Redmile Group, LLC | Director, 10% Owner | 1 | $0 | $0 | 2022-05-23 |
| Lux Co-Invest Opportunities, L.P. | 10% Owner | 1 | $0 | $0 | 2022-04-04 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Coman David | Chief Executive Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 49,512 | — | $0 | 0 | SEC↗ |
| Coman David | Chief Executive Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 192,427 | — | $0 | 0 | SEC↗ |
| Coman David | Chief Executive Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 28,899 | — | $0 | 0 | SEC↗ |
| Hubbard John W | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 2,540 | — | $0 | 0 | SEC↗ |
| Hubbard John W | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 24,742 | — | $0 | 0 | SEC↗ |
| Hubbard John W | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 1,378 | — | $0 | 0 | SEC↗ |
| Hubbard John W | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 20,195 | — | $0 | 0 | SEC↗ |
| Rollins Emily | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 1,378 | — | $0 | 0 | SEC↗ |
| Rollins Emily | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 24,742 | — | $0 | 0 | SEC↗ |
| Tiwari Neil | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 1,378 | — | $0 | 0 | SEC↗ |
| Tiwari Neil | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 24,742 | — | $0 | 0 | SEC↗ |
| von Autenried Paul | Other | D To issuer deriv | 2024-03-12 | 2024-03-12 | 24,742 | — | $0 | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 37,222 | — | $0 | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 428 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 25,621 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 45,746 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 6,033 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 2,522 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 28,897 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 4,680 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 3,404 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 6,807 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 5,385 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 7,944 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 23,088 | — | $0 | 0 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | D To issuer deriv | 2024-03-12 | 2024-03-12 | 52,168 | — | $0 | 0 | SEC↗ |
| Green Jeremy | Other | D To issuer deriv | 2024-03-12 | 2024-03-13 | 95,765 | — | $0 | 0 | SEC↗ |
| Green Jeremy | Other | D To issuer deriv | 2024-03-12 | 2024-03-13 | 2,068 | — | $0 | 0 | SEC↗ |
| Faulkner Robert C. | Other | D To issuer deriv | 2024-03-12 | 2024-03-13 | 2,068 | — | $0 | 0 | SEC↗ |
| Coman David | Chief Executive Officer | U Tender | 2024-03-12 | 2024-03-12 | 53,834 | $5.75 | $309.5K | 0 | SEC↗ |
| Coman David | Chief Executive Officer | D To issuer | 2024-03-12 | 2024-03-12 | 30,781 | $5.75 | $177.0K | 0 | SEC↗ |
| Hubbard John W | Other | U Tender | 2024-03-12 | 2024-03-12 | 2,050 | $5.75 | $11.8K | 0 | SEC↗ |
| Rollins Emily | Other | U Tender | 2024-03-12 | 2024-03-12 | 2,050 | $5.75 | $11.8K | 0 | SEC↗ |
| Tiwari Neil | Other | U Tender | 2024-03-12 | 2024-03-12 | 2,050 | $5.75 | $11.8K | 0 | SEC↗ |
| von Autenried Paul | Other | U Tender | 2024-03-12 | 2024-03-12 | 2,302 | $5.75 | $13.2K | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer | 2024-03-12 | 2024-03-12 | 35,115 | $5.75 | $201.9K | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | U Tender | 2024-03-12 | 2024-03-12 | 14,579 | $5.75 | $83.8K | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer | 2024-03-12 | 2024-03-12 | 22,212 | $5.75 | $127.7K | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | U Tender | 2024-03-12 | 2024-03-12 | 9,070 | $5.75 | $52.2K | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | U Tender | 2024-03-12 | 2024-03-12 | 15,753 | $5.75 | $90.6K | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer | 2024-03-12 | 2024-03-12 | 24,644 | $5.75 | $141.7K | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | U Tender | 2024-03-12 | 2024-03-12 | 41,891 | $5.75 | $240.9K | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer | 2024-03-12 | 2024-03-12 | 12,864 | $5.75 | $74.0K | 0 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | U Tender | 2024-03-12 | 2024-03-12 | 9,247 | $5.75 | $53.2K | 0 | SEC↗ |
| Green Jeremy | Other | U Tender | 2024-03-12 | 2024-03-13 | 1,017,203 | $5.75 | $5.85M | 0 | SEC↗ |
| Faulkner Robert C. | Other | U Tender | 2024-03-12 | 2024-03-13 | 26,791 | $5.75 | $154.0K | 0 | SEC↗ |
| Jaguar Holding Co I, LLC | 10% Owner | U Tender | 2024-03-12 | 2024-03-14 | 868,990 | $5.75 | $5.00M | 0 | SEC↗ |
| Thermo Fisher Scientific Powde | 10% Owner | U Tender | 2024-03-12 | 2024-03-14 | 868,990 | $5.75 | $5.00M | 0 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | M Exercise deriv | 2024-03-10 | 2024-03-12 | 8,713 | — | $0 | 17,426 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | M Exercise | 2024-03-10 | 2024-03-12 | 8,713 | — | $0 | 12,253 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | F Tax w/h | 2024-03-10 | 2024-03-12 | 3,006 | $5.73 | $17.2K | 9,247 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | M Exercise deriv | 2023-10-07 | 2023-10-10 | 100,000 | — | $0 | 200,000 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | F Tax w/h | 2023-10-07 | 2023-10-10 | 29,201 | $0.41 | $12.0K | 70,799 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | M Exercise | 2023-10-07 | 2023-10-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | M Exercise deriv | 2023-08-12 | 2023-08-15 | 355,549 | — | $0 | 711,097 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2023-08-12 | 2023-08-15 | 230,882 | — | $0 | 461,764 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | M Exercise deriv | 2023-08-12 | 2023-08-15 | 256,207 | — | $0 | 512,414 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | M Exercise deriv | 2023-08-12 | 2023-08-15 | 288,972 | — | $0 | 577,942 | SEC↗ |
| Coman David | Chief Executive Officer | M Exercise deriv | 2023-08-12 | 2023-08-15 | 495,122 | — | $0 | 990,243 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | M Exercise | 2023-08-12 | 2023-08-15 | 355,549 | — | $0 | 1,076,434 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | F Tax w/h | 2023-08-12 | 2023-08-15 | 86,577 | $0.44 | $38.1K | 989,857 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2023-08-12 | 2023-08-15 | 230,882 | — | $0 | 1,174,970 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | F Tax w/h | 2023-08-12 | 2023-08-15 | 79,839 | $0.44 | $35.1K | 1,095,131 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | M Exercise | 2023-08-12 | 2023-08-15 | 256,207 | — | $0 | 700,490 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | F Tax w/h | 2023-08-12 | 2023-08-15 | 74,813 | $0.44 | $32.9K | 625,677 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | F Tax w/h | 2023-08-12 | 2023-08-15 | 84,380 | $0.44 | $37.1K | 807,964 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | M Exercise | 2023-08-12 | 2023-08-15 | 288,972 | — | $0 | 892,344 | SEC↗ |
| Coman David | Chief Executive Officer | M Exercise | 2023-08-12 | 2023-08-15 | 495,122 | — | $0 | 1,836,909 | SEC↗ |
| Coman David | Chief Executive Officer | F Tax w/h | 2023-08-12 | 2023-08-15 | 144,576 | $0.44 | $63.6K | 1,692,333 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | M Exercise deriv | 2023-05-19 | 2023-05-22 | 16,667 | — | $0 | 33,333 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | F Tax w/h | 2023-05-19 | 2023-05-22 | 5,614 | — | $0 | 720,885 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | M Exercise | 2023-05-19 | 2023-05-22 | 16,667 | — | $0 | 726,499 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Rollins Emily | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Rollins Emily | Director | M Exercise deriv | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 0 | SEC↗ |
| Hubbard John W | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Hubbard John W | Director | M Exercise deriv | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 0 | SEC↗ |
| von Autenried Paul | Director | M Exercise deriv | 2023-05-11 | 2023-05-12 | 46,040 | — | $0 | 0 | SEC↗ |
| von Autenried Paul | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Tiwari Neil | Director | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Tiwari Neil | Director | M Exercise deriv | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 0 | SEC↗ |
| Bryenton Troy | Chief Technology Officer | A Award deriv | 2023-05-11 | 2023-05-12 | 494,853 | — | $0 | 494,853 | SEC↗ |
| Rollins Emily | Director | M Exercise | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Hubbard John W | Director | M Exercise | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 40,983 | SEC↗ |
| von Autenried Paul | Director | M Exercise | 2023-05-11 | 2023-05-12 | 46,040 | — | $0 | 46,040 | SEC↗ |
| Tiwari Neil | Director | M Exercise | 2023-05-11 | 2023-05-12 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Faulkner Robert C. | Director | A Award | 2023-05-11 | 2023-05-15 | 494,853 | $0.25 | $123.7K | 535,836 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award | 2023-05-11 | 2023-05-15 | 494,853 | $0.25 | $123.7K | 20,344,070 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 1,270,739 | — | $0 | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 247,000 | — | $0 | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 238,095 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 467,351 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 457,466 | — | $0 | 0 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 185,897 | — | $0 | 0 | SEC↗ |
| Coman David | Chief Executive Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 981,437 | — | $0 | 0 | SEC↗ |
| Coman David | Chief Executive Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 557,692 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 200,549 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 442,754 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 1,020,754 | — | $0 | 0 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | D To issuer deriv | 2023-04-28 | 2023-05-02 | 211,538 | — | $0 | 0 | SEC↗ |
| Pellizzari Christine A | Chief Legal and HR Officer | A Award | 2023-04-28 | 2023-05-02 | 702,332 | — | $0 | 709,832 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award | 2023-04-28 | 2023-05-02 | 444,283 | — | $0 | 444,283 | SEC↗ |
| Coman David | Chief Executive Officer | A Award | 2023-04-28 | 2023-05-02 | 615,650 | — | $0 | 1,341,787 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award | 2023-04-28 | 2023-05-02 | 257,320 | — | $0 | 944,088 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award | 2023-04-28 | 2023-05-02 | 492,916 | — | $0 | 603,372 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | A Award deriv | 2023-03-10 | 2023-03-15 | 522,793 | — | $0 | 522,793 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | P Buy | 2022-11-17 | 2022-11-17 | 5,000 | $0.81 | $4.1K | 5,000 | SEC↗ |
| von Autenried Paul | Director | A Award deriv | 2022-10-07 | 2022-10-11 | 46,040 | — | $0 | 46,040 | SEC↗ |
| Shipton Michael | Chief Commercial Officer | A Award deriv | 2022-10-07 | 2022-10-11 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Coman David | Chief Executive Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 1,485,365 | — | $0 | 1,485,365 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 1,066,646 | — | $0 | 1,066,646 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 768,621 | — | $0 | 768,621 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 692,646 | — | $0 | 692,646 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 866,914 | — | $0 | 866,914 | SEC↗ |
| Geffon Steven | Chief Commercial Officer | A Award deriv | 2022-08-12 | 2022-08-16 | 563,414 | — | $0 | 563,414 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | M Exercise deriv | 2022-06-29 | 2022-07-01 | 68,075 | — | $0 | 68,075 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | M Exercise | 2022-06-29 | 2022-07-01 | 68,075 | $0.28 | $19.1K | 110,456 | SEC↗ |
| Green Jeremy | Director, 10% Owner | J Other | 2022-06-13 | 2022-06-15 | 6,472,228 | $3.38 | $21.88M | 19,849,217 | SEC↗ |
| Green Jeremy | Director, 10% Owner | J Other | 2022-06-13 | 2022-06-15 | 6,472,228 | $3.38 | $21.88M | 19,849,217 | SEC↗ |
| Hubbard John W | Director | A Award deriv | 2022-05-23 | 2022-05-24 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Goulburn Adam | Director | A Award deriv | 2022-05-23 | 2022-05-24 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Rollins Emily | Director | A Award deriv | 2022-05-23 | 2022-05-24 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Tiwari Neil | Director | A Award deriv | 2022-05-23 | 2022-05-24 | 40,983 | — | $0 | 40,983 | SEC↗ |
| Redmile Group, LLC | Director, 10% Owner | A Award | 2022-05-23 | 2022-05-25 | 40,983 | $3.05 | $125.0K | 19,849,217 | SEC↗ |
| Faulkner Robert C. | Director | A Award | 2022-05-23 | 2022-05-25 | 40,983 | $3.05 | $125.0K | 40,983 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2022-05-20 | 2022-05-24 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2022-04-20 | 2022-04-21 | 56,731 | — | $0 | 158,844 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2022-04-20 | 2022-04-21 | 3,905 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2022-04-20 | 2022-04-21 | 3,905 | $0.85 | $3.3K | 630,037 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2022-04-20 | 2022-04-21 | 56,731 | $0.40 | $22.7K | 686,768 | SEC↗ |
| Lux Co-Invest Opportunities, L | 10% Owner | J Other | 2022-04-04 | 2022-04-06 | 2,914,667 | — | $0 | 8,743,999 | SEC↗ |
| Goulburn Adam | Director | J Other | 2022-04-04 | 2022-04-06 | 2,481 | — | $0 | 2,481 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 211,538 | — | $0 | 211,538 | SEC↗ |
| Geffon Steven | Chief Commercial Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 211,538 | — | $0 | 211,538 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 238,095 | — | $0 | 238,095 | SEC↗ |
| Coman David | Chief Executive Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 557,692 | — | $0 | 557,692 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 185,897 | — | $0 | 185,897 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2022-01-07 | 2022-01-11 | 200,549 | — | $0 | 200,549 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2021-12-02 | 2022-02-25 | 11,345 | — | $0 | 215,575 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2021-12-02 | 2022-02-25 | 977 | — | $0 | 3,905 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2021-12-02 | 2022-02-25 | 977 | $0.85 | $830 | 614,787 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2021-12-02 | 2022-02-25 | 11,345 | $0.40 | $4.5K | 626,132 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2021-10-28 | 2022-02-25 | 68,074 | — | $0 | 226,920 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2021-10-28 | 2022-02-25 | 68,074 | $0.40 | $27.2K | 613,810 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2021-10-25 | 2022-02-25 | 4,538 | — | $0 | 0 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise deriv | 2021-10-25 | 2022-02-25 | 5,857 | — | $0 | 4,882 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2021-10-25 | 2022-02-25 | 4,538 | $0.85 | $3.9K | 539,879 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | M Exercise | 2021-10-25 | 2022-02-25 | 5,857 | $0.85 | $5.0K | 545,736 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award deriv | 2021-10-07 | 2021-10-12 | 41,363 | — | $0 | 41,363 | SEC↗ |
| Faulkner Robert C. | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 41,363 | — | $0 | 41,363 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 1,020,754 | — | $0 | 1,020,754 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 442,754 | — | $0 | 442,754 | SEC↗ |
| Geffon Steven | Chief Commercial Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 1,017,351 | — | $0 | 1,017,351 | SEC↗ |
| Coman David | Chief Executive Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 981,437 | — | $0 | 981,437 | SEC↗ |
| Goulburn Adam | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 27,575 | — | $0 | 27,575 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 467,351 | — | $0 | 467,351 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2021-10-07 | 2021-10-12 | 247,000 | — | $0 | 247,000 | SEC↗ |
| Rollins Emily | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 27,575 | — | $0 | 27,575 | SEC↗ |
| Hubbard John W | Director | A Award deriv | 2021-10-07 | 2021-10-12 | 27,575 | — | $0 | 27,575 | SEC↗ |
| Tiwari Neil | Director | A Award deriv | 2021-10-07 | 2021-10-15 | 27,575 | — | $0 | 27,575 | SEC↗ |
| Geffon Steven | Chief Commercial Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 914,916 | — | $0 | 914,916 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 93,602 | — | $0 | 93,602 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 136,147 | — | $0 | 136,147 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 136,147 | — | $0 | 136,147 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 1,270,710 | — | $0 | 1,270,710 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 294,986 | — | $0 | 294,986 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 10,739 | — | $0 | 10,739 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 4,538 | — | $0 | 4,538 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 457,455 | — | $0 | 457,455 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2021-10-06 | 2021-10-08 | 914,916 | — | $0 | 914,916 | SEC↗ |
| Coman David | CEO and Director | A Award deriv | 2021-10-06 | 2021-10-08 | 3,848,459 | — | $0 | 3,848,459 | SEC↗ |
| Hubbard John W | Director | A Award deriv | 2021-10-06 | 2021-10-08 | 403,896 | — | $0 | 403,896 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 50,428 | — | $0 | 50,428 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 107,692 | — | $0 | 107,692 | SEC↗ |
| Geffon Steven | Chief Commercial Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 115,079 | — | $0 | 115,079 | SEC↗ |
| Coman David | Chief Executive Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 577,984 | — | $0 | 577,984 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 120,644 | — | $0 | 120,644 | SEC↗ |
| Pellizzari Christine A | Chief Legal Officer | A Award deriv | 2021-10-06 | 2021-10-12 | 8,541 | — | $0 | 8,541 | SEC↗ |
| Hubbard John W | Director | A Award deriv | 2021-10-06 | 2021-10-12 | 50,802 | — | $0 | 50,802 | SEC↗ |
| Green Jeremy | Director, 10% Owner | A Award | 2021-10-06 | 2021-10-08 | 14,750,786 | — | $0 | 19,750,786 | SEC↗ |
| Forman Darcy | Chief Delivery Officer | A Award | 2021-10-06 | 2021-10-08 | 42,381 | — | $0 | 42,381 | SEC↗ |
| Cotliar Jonathan | Chief Medical Officer | A Award | 2021-10-06 | 2021-10-08 | 533,264 | — | $0 | 533,264 | SEC↗ |
| Zaranek Mike | Chief Financial Officer | A Award | 2021-10-06 | 2021-10-08 | 322,783 | — | $0 | 322,783 | SEC↗ |
| Coman David | CEO and Director | A Award | 2021-10-06 | 2021-10-08 | 723,320 | — | $0 | 723,320 | SEC↗ |
| Green Jeremy | 10% Owner | A Award | 2021-10-06 | 2021-10-18 | 14,808,234 | — | $0 | 19,808,234 | SEC↗ |